Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
advisory committee
Biotech
Lilly's donanemab sails through FDA meeting with 2 yes votes
Lilly’s Alzheimer’s drug sailed through an FDA meeting, with panelists praising the therapy as innovative—while cautioning about a lack of data on subgroups.
Annalee Armstrong
Jun 10, 2024 5:11pm
Lykos' MDMA treatment rejected by FDA committee
Jun 5, 2024 10:20am
Guardant preps for FDA review of colorectal cancer blood test
May 13, 2024 1:48pm
FDA wants to hear from you on future of adcomm meetings
Apr 29, 2024 12:51pm
FDA's Richard Pazdur explains confirmatory trial rejection, more
Apr 8, 2024 6:00am
FDA panel supports Abbott's TriClip in tricuspid regurgitation
Feb 14, 2024 11:05am